Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Omvoh® (mirikizumab-mrkz) – New indication
January 15, 2025 - Eli Lilly announced the FDA approval of Omvoh (mirikizumab-mrkz), for the treatment of moderately to severely active Crohn’s disease (CD) in adults.
